AIMS: The analysis of randomized controlled trials with incomplete binary outcome data is challenging. We develop a general method for exploring the impact of missing data in such trials, with a focus on abstinence outcomes. DESIGN: We propose a sensitivity analysis where standard analyses, which could include 'missing = smoking' and 'last observation carried forward', are embedded in a wider class of models. SETTING: We apply our general method to data from two smoking cessation trials. PARTICIPANTS: A total of 489 and 1758 participants from two smoking cessation trials. MEASUREMENTS: The abstinence outcomes were obtained using telephone interviews. FINDINGS: The estimated intervention effects from both trials depend on the sensitivity par...
Background The importance of randomization in clinical trials has long been acknowledged for avoidin...
Background The importance of randomization in clinical trials has long been acknowledged for avoidin...
Missing data is a potential source of bias in the results of randomised controlled trials (RCTs), wh...
Abstract Background Missing data are common in tobacco studies. It is well known that from the obser...
BACKGROUND: Missing outcome data are very common in smoking cessation trials. It is often assumed th...
Abstract Background Missing outcome data are very common in smoking cessation trials. It is often as...
Background Randomised controlled trials (RCTs) need to be reported so that their results can be unam...
We develop and demonstrate methods to perform sensitivity analyses to assess sensitivity to plausibl...
We develop and demonstrate methods to perform sensitivity analyses to assess sensitivity to plausibl...
Many clinical trials are analysed using an intention-to-treat (ITT) approach. A full application of ...
Although missing outcome data are an important problem in randomized trials and observational studie...
Although missing outcome data are an important problem in randomized trials and observational studie...
In randomized controlled trials (RCTs), a common strategy to increase power to detect a treatment ef...
Evidence-based research in health care has been developed well in recent years. One of the biggest c...
The use of Bayesian statistical methods to handle missing data in biomedical studies has become popu...
Background The importance of randomization in clinical trials has long been acknowledged for avoidin...
Background The importance of randomization in clinical trials has long been acknowledged for avoidin...
Missing data is a potential source of bias in the results of randomised controlled trials (RCTs), wh...
Abstract Background Missing data are common in tobacco studies. It is well known that from the obser...
BACKGROUND: Missing outcome data are very common in smoking cessation trials. It is often assumed th...
Abstract Background Missing outcome data are very common in smoking cessation trials. It is often as...
Background Randomised controlled trials (RCTs) need to be reported so that their results can be unam...
We develop and demonstrate methods to perform sensitivity analyses to assess sensitivity to plausibl...
We develop and demonstrate methods to perform sensitivity analyses to assess sensitivity to plausibl...
Many clinical trials are analysed using an intention-to-treat (ITT) approach. A full application of ...
Although missing outcome data are an important problem in randomized trials and observational studie...
Although missing outcome data are an important problem in randomized trials and observational studie...
In randomized controlled trials (RCTs), a common strategy to increase power to detect a treatment ef...
Evidence-based research in health care has been developed well in recent years. One of the biggest c...
The use of Bayesian statistical methods to handle missing data in biomedical studies has become popu...
Background The importance of randomization in clinical trials has long been acknowledged for avoidin...
Background The importance of randomization in clinical trials has long been acknowledged for avoidin...
Missing data is a potential source of bias in the results of randomised controlled trials (RCTs), wh...